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Abstract
Objective
To investigate the effectiveness of a multi-facetted blended eHealth intervention, called
SDM-Digital Intake (SDM-DI), in which patients and clinicians are supported in Shared Deci-
sion Making during the intake process.
Methods
The study is a two-arm matched-paired cluster Randomised Controlled Trial in a specialist
mental health outpatient setting with two conditions: SDM-DI and Intake As Usual (IAU).
Four intake teams were allocated to each arm. All patients who followed an intake, were
asked to participate if they were capable to complete questionnaires. Decisional Conflict
(DC), referring to patients’ engagement and satisfaction with clinical decisions, was the pri-
mary outcome. Secondary outcomes were patient participation, applying Shared Decision
Making (SDM), working alliance, treatment adherence and symptom severity. Effects were
measured at two weeks (T1) and two months (T2) after intake. Multilevel regression and
intention-to-treat analyses were used. Additionally, the influence of subgroups and interven-
tion adherence on DC were explored.
Results
At T1, 200 patients participated (47% intervention, 53% control), and at T2 175 patients
(47% intervention, 53% control). At T1 and T2, no differences were found between condi-
tions on DC. Subgroup analyses showed that effects of SDM-DI on DC were not modified by
primary diagnoses mood, anxiety and personality disorders. Compared to IAU, at T2,
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patients reported positive effects of SDM-DI on SDM (ȕ 7.553, p = 0.038, 95%CI:0.403–
14.703, d = 0.32) and reduction of symptoms (ȕ -7.276, p = 0.0497, 95%CI:-14.544–-0.008,
d = -0.43). No effects were found on patient participation, working alliance and treatment
adherence. Exploratory analyses demonstrated that if SDM was applied well, patients
reported less DC (ȕ = -0.457, p = 0.000, 95%CI:-0.518–-0.396, d = -1.31), which was associ-
ated with better treatment outcomes.
Conclusion
Although, this trial fails to demonstrate that SDM-DI by itself is sufficient to reduce DC,
the results are encouraging for further efforts in improving and implementing the SDM
intervention.
Introduction
Background
Although the beneficial effects of Shared Decision Making (SDM) in mental health care are
supported by several studies [1–5], to date there is still much to improve in the degree of
patient participation in decision making about treatment [6–8]. Previous research [1–5]
pointed out that SDM in mental health care can lead to better informed patients, more patient
satisfaction and an improvement in treatment engagement, which, in turn, can have a positive
impact on clinical outcomes. Nevertheless, patients in mental health care regularly experience
low levels of engagement and satisfaction regarding clinical decision making [8], while they do
prefer to be (more) involved in decision making with regard to their treatment [6,7,9–12].
SDM is the collaborative approach in which patients, relatives and clinicians share available
information during clinical decision making and where patients, along with relatives, are sup-
ported to participate actively in decision making about their treatment [13]. To enhance SDM,
it is important to support both patients and clinicians in these relatively new way of working
[7,14,15]. Previous studies about the implementation of SDM, have demonstrated the negative
influence of the power imbalance between patients and clinicians on the application of SDM
in clinical practice. These studies also showed the importance to change both clinicians’ and
patients’ attitudes and skills in making shared decisions [7,14].
Rationale
To stimulate the shift towards SDM from the start of treatment, GGz Breburg, a specialist
mental health organisation in the southern part of the Netherlands, invested in the develop-
ment and implementation of a novel multi-facetted digital SDM intervention in the intake
process [16]. This intervention, called SDM-Digital Intake (SDM-DI), consisted of a blended
eHealth intervention integrated with the initial Routine Outcome Measurement (ROM), peer
workers support and clinicians’ training. ROM implies regular measurements of clinical out-
comes during treatment, which provides feedback on the patients’ progress in treatment. The
initial ROM is regularly planned in the intake process [17,18]. The SDM-DI initiative aimed to
target both sides of the dyad, i.e. patients as well as professionals, in order to foster SDM. The
intervention was evaluated in a two-arm cluster Randomised Controlled Trial (RCT). To our
knowledge, no previous RCT has investigated such a multi-facetted digital SDM intervention
facilitating both patients and clinicians in the intake process.
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Objective and hypotheses
This trial aimed to investigate the effects of SDM-Digital Intake (SDM-DI) on the primary out-
come Decisional Conflict (DC), which refers to the degree to which patients were engaged in
and felt comfortable about important clinical decisions [8,19], and the secondary outcomes
patient participation in decision making, the working alliance, adherence to treatment and
symptom severity. It was hypothesized that, compared to the Intake As Usual (IAU), the inter-
vention: 1) diminishes patients’ perception of DC, 2) fosters patients’ participation, 3) stimu-
lates the SDM process, 3) enhances the working alliance between patients and clinicians, 4)
leads to more treatment adherence, and 5) improves treatment outcome.
Materials and methods
Ethics statement
The Medical Ethics Committee of VU University Medical Centre Amsterdam, The Nether-
lands reviewed the study and declared that the Medical Research Involving Human Subjects
Act (WMO) did not apply to this study (reference number: 2015.434). All participating
patients gave written informed consent before filling in the research questionnaires.
Trial design
This study was a two-arm matched-pair cluster randomised controlled trial. To keep contami-
nation to a minimum, we used a cluster design at team level with pairs of similar teams within
the same department, treating a similar population of patients in the same geographical catch-
ment area, which is considered a good procedure in RCTs evaluating interventions at clini-
cians’ level [20]. In this study, the application of SDM-Digital Intake (SDM-DI) was compared
with the Intake As Usual (IAU). The design of this study has been described in more detail
elsewhere [16]. The trial is registered in the Dutch trial register with number: NTR5677, regis-
tration date: 17 January 2016 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=
5677). Results are presented in accordance with the CONSORT statement for cluster rando-
mised controlled trials [21].
Settings and location
This trial was conducted in four outpatient departments of the specialist mental health care
organisation GGz Breburg located in the southern part of the Netherlands. The SDM-DI inter-
vention was intended to be suitable for patients with various diagnoses (depression, anxiety
and personality disorders), and was therefore tested in two outpatient departments specialised
in depression and anxiety disorders, and two outpatient departments specialised in personality
disorders. Each of the two departments, which were specialised in the same patient group,
where working in separate catchment areas. The four participating departments consisted of
two multidisciplinary intake-teams each, in which initial treatment decisions are made.
Participants and eligibility criteria
In total eight intake teams from four departments operating in two catchment areas partici-
pated in this trial. Research assistants consecutively invited each new patient, for whom a full
intake (SDM-DI or IAU) was planned, to participate in this study. Patients were excluded if
they did not speak or read the Dutch language or were incapable to complete questionnaires
because of cognitive functioning or an ongoing crisis. Patients enrolled after receiving face to
face and written information about the study given by the research assistants, and after giving
written informed consent.
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Randomisation of clusters
Cluster randomisation at the level of the four pairs of intake teams was performed using com-
puter-generated random numbers. According to the matched-pair cluster randomised design,
the randomisation sequence was performed per block of two intake-teams using a SPSS-syntax
which generated a random number (0 = control/IAU, 1 = intervention/SDM-DI). This syntax
was prepared by a data manager with no involvement in this trial. The random allocation
sequence was conducted by the co-author IE, prior to the start of the intervention and data col-
lection of this study, independent of the participating teams and the primary researcher MM,
who coordinated and conducted the trial.
Four teams were randomised to the intervention group and four teams to the control
group. To reduce the risk of contamination from the intervention to the control condition, the
participating teams had their own multidisciplinary team consultation. Furthermore, clini-
cians and patients participated in one condition. Patients who were planned for an intake con-
sultation with clinicians of the intervention group, were automatically assigned to the
intervention and received SDM-Digital Intake (SDM-DI). Patients who had the first intake
appointment with clinicians of the control group, followed the intake as usual (IAU). Planning
of these intake consultations was conducted by secretaries with no involvement in the study,
according to the availability of time in the agendas of patients and intake clinicians. There was
no influence of other factors on this planning process.
Blinding
Due to cluster randomisation at team level and the nature of the intervention (i.e. clinicians
had to guide the digital intake approach and patients did follow eHealth modules), blinding of
the clinicians and patients was not feasible. To reduce the risk of bias, research assistants, inde-
pendent of the research team and participating teams, performed the inclusion of patients and
carried out the data collection. During the inclusion process, the independent research assis-
tants were blinded to the allocation of the condition.
Interventions
The multi-facetted intervention, called SDM-Digital Intake (SDM-DI), aimed to target both
sides of the dyad, i.e. patients as well as professionals, in order to foster SDM. SDM-DI is
formed by a digital intake approach incorporating a blended eHealth intervention integrated
with Routine Outcome Monitoring (ROM), support of peer workers and training of clinicians.
Patients participating in the intervention group were also stimulated to involve a relative in
their intake process. The intervention is briefly described below. A comprehensive description
can be found elsewhere [16].
Blended eHealth intervention integrated with ROM. Two eHealth modules were offered
in order to explore treatment needs, expectations and preferences of patients aiming to sup-
port patients in preparing themselves, along with relatives, for the intake consultations. The
initial ROM, which measured symptom severity, was integral part of the eHealth modules.
ROM implies regular measurements of clinical outcomes during treatment, which provides
feedback on the patients’ progress in treatment. The initial ROM is regularly planned in the
intake process [17,18]. While following eHealth, patients completed the first ROM, had direct
access to their ROM results, and got the opportunity to have contact with trained peer workers.
Peer workers have life experience in mental illness and treatment, and could help patients
while following the eHealth modules and with preparations for the intake and choices in
treatment.
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Intake consultations. The results of the completed modules and ROM were visible for
patients and clinicians as well. Patients were stimulated to use their own feedback reports, with
personalised graphics about their mental health problems and the impact on daily life, to pre-
pare the intake consultations and bring them to these consultations. The assertion was that
patients who were better prepared for the intake, would be more able to actively participate in
the dialogue with their intake clinicians about choices in treatment. To make sure that patients
and clinicians have sufficient time to discuss the preparation by eHealth and ROM, in the
intervention group, the first intake consultation was extended from 60 to 90 minutes.
Training of clinicians. The clinicians of the intervention group followed a training of
three half-day sessions aimed to stimulate and facilitate the new way of working. The training
was given by a trainers couple formed by a peer worker and clinician and contained explana-
tions of, instructions on and exercises in recovery supported care and the application of SDM
[22] using eHealth and ROM as sources of personalised information. During the course of the
study, the intervention teams organised at least one supervision session, where clinicians eval-
uated and discussed their experiences in SDM-DI with colleagues.
Intake as usual. The control group consisted of an Intake As Usual (IAU), which means
that patients in the control group did not follow the blended eHealth intervention, did not
complete the initial ROM in the eHealth portal, had no digital access to their own ROM results
and could not consult a peer worker in the intake process. The time of the first intake consulta-
tion in the control group was standard 60 minutes. Furthermore, the intake clinicians of the
control group did not follow training in recovery supported care and the application of SDM
using eHealth and ROM. In both arms, the multidisciplinary team consultation fulfilled the
usual role of checking the quality of the treatment choices.
Outcomes
Measurements. To prevent socially desirable answers and an undesired influence of the
research team or clinicians on the results several precautions were taken. First, data were col-
lected by independent research assistants. Second, the outcomes, Decisional Conflict (DC),
patient participation, SDM process and working alliance, were measured with separate instru-
ments that were included for research purposes only. Third, the results on these research
instruments were not visible for patients and clinicians during intake and treatment. The
research instruments were completed two weeks (T1) and two months (T2) after intake, and
thus measured both the effects of the intervention. Furthermore, two weeks after intake (T1),
clinicians answered questions about SDM regarding their patients. Patients and clinicians
received a link by email to complete the questionnaires and if necessary received, after 7, 9 and
14 days, reminders by email or phone. If patients did not use internet, they received paper
questionnaires by post.
The other outcomes no-show, drop-out and symptom severity (i.e. ROM) were derived
from the electronic patient records. Participants in the intervention and control group com-
pleted the regular initial ROMmeasurement at baseline (T0) and the follow up ROMmeasure-
ments at T1 and T2.
Primary outcome. Decisional Conflict (DC) was measured in patients using the revised,
validated Decisional Conflict Scale (DCS) [19], which was translated into Dutch [22]. Each of
the 16 items is scored from 0 (strongly agree) to 4 (strongly disagree). Besides a total score, the
DCS includes five dimensions (information, support, clarification of values, certainty and deci-
sion quality). Higher scores indicate more DC, which means that patients report to have
achieved less information, less support, less clarification, less certainty and poorer decision
quality about decision making. To calculate the total scale and scores of the five dimensions
Supporting Shared Decision Making in mental health care during intake
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the item scores were summed, divided by the number of items and multiplied by 25. The
scores thus range from 0 to 100 [19]. The internal consistencies of the total score and five
dimensions of the Dutch version of the DCS calculated in this study population were good
(Total scale ċ = .95, subdomains ċ .77). To compare patients’ and clinicians’ views on DC,
additionally DC was measured on a Visual Analogue (VAS) 10-point scale (item: ‘to what
extent do you agree with the decision taken?’), filled out at T1 by both patients and clinicians
(regarding their patients).
Secondary outcomes. We used the following validated self-report questionnaires to mea-
sure the secondary outcomes: Patient Participation Questionnaire (PPQ) [16], the patients’
and clinicians’ versions of the Shared Decision Making-Questionnaire-9 (SDM-Q-9) [23],
Patient-Doctor Relationship Questionnaire-9 (working alliance) [24] and Symptom Question-
naire-48 (SQ-48) [25,26]. The Cronbach’s alphas of the total scores of these secondary out-
come questionnaires in this study population were good (PPQ ċ = .90; SDM-Q-9 patient ċ =
.95; SDM-Q-9 clinician ċ = .86; PDRQ-9 ċ = .97; SQ-48 ċ = .93). At the end of the study,
patients received an additional question about the extent to which they achieved their personal
treatment goals [16]. Finally, treatment adherence was assessed by the number of missed
appointments (no-shows) and patients who did not want to proceed with treatment (treatment
drop out) [16].
Intervention integrity. To check the intervention integrity, process variables were col-
lected. These variables report the degree of completion of eHealth modules and the frequency
of consulting peers.
Patients’ and clinical characteristics. Patients’ and clinical characteristics were collected
at baseline. The following data were registered in the Electronical Patient Records (EPR): gen-
der, age, educational level, primary diagnosis, symptom severity, motivation to start treatment
(own initiative or by pressure of the social environment), length of previous treatment (at GGz
Breburg in weeks) and length of waiting time (from registration to first intake consultation in
weeks).
Sample size
A sample size calculation prior to the study [16] was performed to detect a difference between
the two arms with an expected clinically relevant medium effect size on the primary outcome
patients’ rated Decisional Conflict. We were, as far as we know, the first to examine the effects
of such an intensive multi-facetted eHealth intervention during intake supporting patients and
clinicians in Shared Decision Making, performed in specialist mental health care using Deci-
sional Conflict experienced by patients as a primary outcome. Therefore, it was difficult to
determine an exact estimate of the effect size for the primary outcome. We used a medium
effect size of d = 0.5, because this is considered to be a clinically meaningful effect.
A sample size of 65 patients per arm was needed to obtain an usual power of Č = .80 with an
alpha set at 0.05 (two tailed) [27]. Adjustment for clustering within teams assumed an expected
intra cluster correlation coefficient (ICC) of 0.01. Although the cluster variation can rarely be
estimated in advance, we expected the ICC at team level to be low because of the stratified ran-
domisation between clusters (matched-paired design) of participating teams from a single
mental health organisation [28,29]. Moreover, a reanalysis of cluster-based studies in primary
care [28] demonstrated also a low level of clustering (median ICC of 0.01), even between dif-
ferent general practices.
We calculated [21,30] that with an ICC of 0.01 and an inflation factor of 1.18 at team level a
sample size of 77 completers per arm was needed (Design Effect (DE) = 1 +(m-1)  ICC
(m = number of subjects in a cluster) => DE = 1 + (77/4-1)0.01 = DE 1.18). Taking into
Supporting Shared Decision Making in mental health care during intake
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account a dropout rate of 10%, we calculated that at least 88 patients had to be included per
arm to certify sufficient power.
Statistical methods
The analyses were conducted using intention-to-treat principles. Multi-level analyses were
performed in MLwiN 2.21 software. The other analyses were performed in SPSS 19.0.
Descriptives and drop-out analyses. Descriptive analyses were conducted in order to
analyse patients’ characteristics and intervention integrity. Attrition analyses were performed
by means of a logistic regression analysis in order to test for selective drop-out between T1 and
T2. If participants had answered at least 80% of the items on a questionnaire, missing items
were imputed with the mean value of the completed items.
Primary and secondary outcomes. To correct for possible clustering of the data and to
handle missing data [31], the analyses of the primary and secondary outcomes, which mea-
sured effects at T1 and T2, were performed using linear multilevel regression analysis (MLA)
with three levels (teams, couples of intake-clinicians and patients). Severity of symptoms,
measured by SQ-48 at three measurement moments (T0, T1, T2) were analysed using longi-
tudinal MLA. We performed this longitudinal analysis with four levels (teams, couples of
intake-clinicians, patients and multiple measurements within patients) and adjusted for the
baseline score T0. Both the overall effects (all measurements T1 and T2) as the effects at the
separate measurement moments (T1, T2 separately) were calculated. The analyses of the out-
comes were performed with a two-tailed 0.05 significance level. The effect sizes (Cohen’s d)
were calculated by dividing the between-group difference by the pooled SD. The thresholds
for interpreting the effect size were: Small 0.00–0.32, Medium 0.33–0.55 and Large 0.56
[32].
Additional analyses. The differences in patients’ and clinicians’ views on the application
of Shared Decision Making (SDM-Q-9) and agreement with clinical decisions (DC VAS) were
tested using dependent t-tests. Furthermore, post-hoc analyses were performed for the pri-
mary outcome Decisional Conflict (DC). We assessed potential effect modification by primary
diagnoses, motivation for treatment, previous treatment and waiting time. Interactions were
tested for significance at a p-value of 0.1. We also investigated the influence of intervention
integrity on DC. Finally, we explored the influence of applying SDM on the primary outcome
DC and the association between DC and symptom severity.
Results
Recruitment and participants flow
Inclusion started in October 2016 and ended in June 2017, when the required sample size
was reached. Follow-up measurements were completed in August 2017. Eight teams (four
intervention teams with in total 29 couples of intake clinicians, who jointly performed the
intake, and four control teams with in total 27 couples of intake clinicians) of four depart-
ments from one specialist mental health care organisation participated in the trial. As shown
in Fig 1, 200 patients (94 intervention, 47%; and 106 control, 53%) gave written informed
consent and responded to the first measurement (T1). These 200 patients were included in
the analyses. In total 175 patients (83 intervention, 47%; and 92 control, 53%) filled out the
follow-up measurement at 2 months (T2). The range of participating patients per team was
17 to 37 (mean 25 patients) and per couple of intake clinicians the range was 1 to 23 patients
(mean 4.4 patients).
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Loss to follow-up
The dropout rate of patients between T1 and T2 was 13% (11 intervention, 14 control). Num-
bers of dropout were not significantly different between the conditions and dropout rates were
not significantly associated with any patient characteristics (gender, age, educational level, pri-
mary diagnosis, treatment motivation). Reasons for dropout were: 1) no longer willing to fill
out research questionnaires (i.e. withdrawal of informed consent) (80%), 2) not responding to
reminders (17%), 3) death during study period (3%).
Baseline characteristics
Table 1 presents patients’ and clinical characteristics at baseline in terms of gender, age, educa-
tional level, primary diagnosis, symptom severity (SQ48 total score) at baseline, treatment
motivation, length of waiting till first intake consultation (in weeks) and previous treatment at
GGz Breburg (in weeks). At baseline, these characteristics were equally distributed over the
two arms.
Fig 1. Flow chart RCT Shared DecisionMaking in a digital intake approach (Consort 2010).
https://doi.org/10.1371/journal.pone.0199795.g001
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Intention to treat analyses
Tables 2 and 3 show the effects of the intervention SDM-DI on the primary and secondary out-
comes. At first, overall effects (T1 and T2) were reported. Second, the results at T1 and T2
were shown separately.
Primary outcome. In the intention-to-treat analyses, no significant differences between
SDM-DI and IAU on the total scale and subdomains of the primary outcome DC were found
(Table 2). We found no evidence for clustering of effects on the primary outcome at team level
(ICC = 0), which was the unit of randomisation. At the level of intake clinicians we found a sig-
nificant cluster effect with an ICC of 0.10. No significant differences were found between the
arms for the patients’ and clinicians’ reported version of the DC VAS scale. When comparing
the patients’ and clinicians’ reported DC VAS at T1, irrespective of the condition, clinicians
scored more positive about the application of SDM (meandiff 2.746, sd 3.873, p<0.001, 95%CI
2.234 to 3.258).
Secondary outcomes. The overall effect (T1 and T2) and the difference at T1 on the sec-
ondary outcome (Table 3) the degree of applying SDM according to patients (SDM-Q-9
patient total scale) were not significant between the two arms. However, at T2, significant dif-
ferences were found between the two arms in favour of the intervention group with regard to
the application of SDM (Č 7.553, p<0.05, 95%CI: 0.403 to 14.703). The difference between
arms at T2 showed an effect size of 0.32.
Looking at the clinicians’ reported SDM-Q-9, completed at T1, the results did not differ sig-
nificantly between the two conditions. When comparing the patients’ and clinicians’ reported
Table 1. Patients’ characteristics.
Total study population
(n = 200)
Intervention group
(n = 94)
Control group
(n = 106)
Gender Female 132 (66%) 66 (70,2%) 66 (62,3%)
Male 68 (34%) 28 (29,8%) 40 (37,7%)
Age Mean age (sd) 38,3 (10,2) 38,6 (10,6) 38,0 (9,8)
Educational level Primary school or Lower secondary education (low) 49 (24,5%) 20 (21,3%) 29 (27,4%)
Higher secondary or intermediate vocational education
(middle)
115 (57,5%) 56 (59,6%) 59 (55,7%)
Higher vocational education or university/Bachelor’s or
Master’s degree (high)
36 (18,0%) 18 (19,1%) 18 (17,0%)
Primary diagnosis  Personality disorder 101 (51,8%) 44 (48,9%) 57 (54,3%)
Anxiety disorder 40 (20,5%) 20 (22,2%) 20 (19,0%)
Mood disorder 39 (20,0%) 21 (23,3%) 18 (17,1%)
Other disorders  15 (7,7%) 5 (5,6%) 10 (9,5%)
SQ48 total score (symptom severity, at T0) 73,3 (23,1) 71,4 (23,0) 75,7 (23,2)
Treatment
motivation 
Own initiative 149 (74,9%) 63 (67,7%) 86 (81,1%)
Influence of others (social environment) 50 (25,1%) 30 (32,3%) 20 (18,9%)
Length of waiting (weeks) 15,7 (55,0) 13,4 (33,4) 17,7 (68,9)
Previous treatment (weeks) 74,9 (120,5) 74,5 (110,2) 75,2 (129,4)
Missing variable/primary diagnosis not registered in EPR n = 5
Other disorders: Group with a diversity of other disorders i.e. Autistic disorder, Attention deficit hyperactivity disorder, Pedophilia, Impulse control disorder,
Adaptive disorder, Partner-relationship problem, Substance dependency, Psychotic disorder NAO, Undifferentiated somatoform disorder, Hypochondria, Disorder in
the body experience.
Missing variable/treatment motivation not registered in EPR n = 1
https://doi.org/10.1371/journal.pone.0199795.t001
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SDM-Q-9 at T1, irrespective of the condition, clinicians scored more positive about the appli-
cation of SDM (meandiff 11.456, sd 28.739, p<0.001, 95%CI 7.310 to 15.602).
Regarding severity of symptoms (SQ-48 total scale), the overall effect (T1 and T2) and the
difference at T1 were not significant between the two arms (Table 3). However, at T2, the
intervention group scored significant better (Č -7.276, p<0.05, 95%CI: -14.544 to -0.008). This
measurement was completed 60 days (median) after baseline. Thus, after a period with a
median of 60 days, patients in the intervention group reported significantly less symptom
severity compared to the control group. The effect size was medium (d = -0.43).
Finally, we found no significant effects of SDM-DI on the secondary outcomes (Table 3):
working alliance and patient participation. Also, adherence to treatment (drop out and no-
shows) and achievement of treatment goals (Č 0.059, p = 0.364, 95%CI -0.068 to 0.186,
d = 0.13) did not differ between the two arms. In the intervention group the treatment drop
out percentage was 4.3% (4 patients) and in the control group 2.8% (3 patients). The mean
number of no-shows of treatment consultations was in each arm the same (mean 0.02 per
patient).
Table 2. Effects of SDM-DI on the primary outcome.
Primary outcome Decisional Conflict
Overall effect (T1 and T2) T1 T2
mean T1
and T2 (sd)
Č 95%CI p Effect
size
mean T1
(sd)
Č 95%CI p Effect
size
mean T2
(sd)
Č 95%CI p Effect
size
Total I 42.78 (sd
16.70)
-1.835 -7.237–
3.567
0.506 -0.10 I 42.97
(18.45)
-3.565 -10.000–
2.870
0.278 -0.10 I 41.33
(19.37)
0.162 -6.545–
6.869
0.964 0.01
C 42.93
(15.97)
C 45.97
(19.59)
C 42.57
(19.21)
Information I 47.49
(20.76)
0.508 -6.603–
7.619
0.889 0.02 I 48.48
(23.76)
-0.858 -9.092–
7.376
0.838 -0.04 I 45.88
(22.64)
2.111 -6.433–
0.655
0.628 0.09
C 45.74
(17.85)
C 49.10
(23.45)
C 42.98
(21.97)
Support I 38.52
(16.95)
-2.119 -7.942–
3.704
0.476 -0.10 I 38.16
(20.83)
-3.195 -10.198–
3.808
0.371 -0.15 I 38.89
(19.41)
-0.884 -8.187–
6.419
0.813 -0.04
C 38.37
(18.29)
C 40.28
(22.50)
C 38.11
(21.13)
Clarification I 45.35
(19.21)
-3.044 -9.765–
3.677
0.375 -0.13 I 46.88
(23.27)
-5.930 -13.907–
2.047
0.145 -0.24 I 43.52
(23.46)
0.289 -8.025–
8.603
0.946 0.01
C 45.88
(19.19)
C 51.72
(25.21)
C 41.57
(22.70)
Certainty I 46.47
(20.48)
-2.346 -7.307–
2.615
0.354 -0.10 I 45.17
(22.38)
-5.892 -12.701–
0.917
0.090 -0.26 I 47.53
(24.95)
1.651 -5.536–
8.838
0.652 0.06
C 47.77
(20.37)
C 51.06
(22.85)
C 45.88
(25.93)
Quality I 37.74
(17.32)
-1.236 -5.474–
3.002
0.567 -0.06 I 37.86
(18.46)
-1.912 -7.749–
3.925
0.521 -0.10 I 38.43
(22.06)
-0.479 -6.639–
5.681
0.879 -0.02
C 38.41
(17.22)
C 39.77
(21.43)
C 38.90
(20.18)
VAS DC
patient
I 6.47 (2.63) -0.048 -0.993–
0.897
0.921 -0.01 I 5.55
(3.51)
-0.294 -1.223–
0.635
0.535 -0.08 I 6.75
(3.12)
0.505 -0.393–
1.403
0.270 0.16
C 6.24
(2.94)
C 5.84
(3.56)
C 6.24
(3.20)
VAS DC
clinician
Not applicable, from clinician’s perspective only
T1 available.
I 8.80
(1.94)
0.083 -0.105–
0.271
0.387 0.17 Not applicable, from clinician’s perspective
only T1 available.
C 8.17
(2.30)
https://doi.org/10.1371/journal.pone.0199795.t002
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Ancillary analyses. Subgroup analyses (Table 4) for the primary outcome patient reported
Decisional Conflict (DC) showed no significant interaction effects between the primary diag-
noses mood, anxiety and personality disorders and trial condition, which means that the effect
of SDM-DI on DC was not influenced by these primary diagnoses for which patient groups
the intervention was intended. We also found no significant interaction effects on the primary
outcome of the parameters treatment motivation (p = 0.114), treatment history (p = 1.000)
and waiting time (p = 0.475) with trial condition.
Table 3. Effects of SDM-DI on the secondary outcomes.
Secondary outcomes Patient Participation (PPQ), Shared Decision Making (SDM-Q-9), Working Alliance (PDRQ-9), Symptom severity (SQ-48)
Overall effect (T1 and T2) T1 T2
Mean T1
and T2 (sd)
Č 95%CI p Effect
size
mean T1
(sd)
Č 95%CI p Effect
size
mean T2
(sd)
Č 95%CI p Effect
size
PPQ I 32.88
(8.53)
0.122 -2.734–
2.978
0.933 0.01 I 30.31
(9.51)
-0.302 -3.650–
3.046
0.860 -0.03 I 34.53
(10.82)
0.100 -2.944–
3.144
0.950 0.01
C 32.93
(8.48)
C 30.42
(10.53)
C 34.43
(10.01)
SDM-Q-9
patient
I 61.83
(20.57)
6.609 -0.874–
14.092
0.083 0.26 I 53.88
(28.20)
6.443 -0.991–
13.877
0.089 0.25 I 62.47
(22.13)
7.553 0.403–
14.703
0.038 0.32
C 55.34
(22.79)
C 60.32
(24.12)
C 54.91
(25.65)
SDM-Q-9
clinician
Not applicable, from clinician’s perspective only
T1 available.
I 69.08
(17.20)
2.203 -3.238–
7.644
0.427 0.15 Not applicable, from clinician’s perspective only
T1 available.
C 65.67
(12.34)
PDRQ-9 I 3.30 (.97) 0.159 -0.217–
0.535
0.408 0.13 I 3.15
(1.15)
0.154 -0.297–
0.605
0.503 0.12 I 3.32
(1.11)
0.089 -0.258–
0.436
0.615 0.08
C 3.18
(1.05)
C 3.02
(1.32)
C 3.23
(1.23)
Overall effect (T1 and T2) T1 (median: 33 days after ROM T0) T2 (median: 60 days after ROM T0)
B 95%CI p d mean T1
(sd)
Č 95%CI p d mean T2
(sd)
Č 95%CI p d
SQ-48 I 69.31
(17.13)
-4.975 -12.217–
2.267
0.178 -0.24 I 69.80
(21.98)
-3.920 -10.549–
2.709
0.247 -0.17 I 64.18
(15.27)
-7.276 -14.544–-
0.008
0.0497 -0.43
C 71.61
(20.09)
C 75.05
(24.01)
C 67.60
(18.45)
C, Control Group; I, Intervention Group; CI, Confidence Interval.
https://doi.org/10.1371/journal.pone.0199795.t003
Table 4. Overall results (T1 and T2) of SDM-DI on the primary outcome DC for diagnosis groups.
Decisional Conflict Total score
Diagnosis groups mean T1 (sd) mean T2 (sd) Č 95% CI p-value Effect size
Personality disorder I 44 patients I 46.21 (20.60) I 42.69 (20.64) -1.582 -8.722–5.558 0.664 -0.12
C 57 patients C 46.76 (15.83) C 44.09 (18.63)
Anxiety disorder I 20 patients I 38.91 (15.28) I 41.67 (23.05) -2.798 -12.181–6.585 0.559 -0.14
C 20 patients C 44.41 (23.65) C 40.89 (16.98)
Mood disorder I 21 patients I 40.23 (18.56) I 41.53 (14.01) -2.221 -12.101–7.659 0.660 -0.12
C 18 patients C 42.10 (21.77) C 44.17 (21.62)
Other disorders I 5 patients I 47.66 (15.44) I 55.08 (10.32) 15.142 -0.765–31.049 0.062 0.84
C 10 patients C 45.78 (21.96) C 25.16 (17.81)
https://doi.org/10.1371/journal.pone.0199795.t004
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Exploratory analyses revealed that, irrespective of the condition, a better application of
SDM, according to the patient reported SDM-Q-9, led to significantly less DC (Č = -0.457,
p<0.001, 95%CI: -0.518 to -0.396) with a large effect size (d = -1.31). We also explored the
influence of DC on treatment outcomes. We found significant positive associations between
less DC at T2 and better clinical outcomes at T2 (Č = 0.227, p<0.05, 95%CI:0.002 to 0.452).
This effect size was medium (d = 0.45). Although, 77% of the patients in the intervention
group completed the first eHealth module and 39% the second module, we found no associa-
tion between the degree of completion of the eHealth modules and the level of patient reported
DC (p = 1.000). Finally, peer workers were hardly consulted. Therefore, we could not explore
the association between the frequency of consulting peer workers and the primary outcome of
this trial.
No adverse or unintended effects of the SDM-DI intervention or IAU were reported.
Discussion
Main findings
This study presents the results of a cluster randomised controlled trial on the effects of
SDM-Digital Intake (SDM-DI) in specialist mental health care aimed to foster Shared Deci-
sion Making. Compared to the Intake As Usual (IAU), no significant effect of SDM-DI was
found on the primary outcome Decisional Conflict (DC) reported by patients and also no sig-
nificant influence was shown on the DC VAS scale reported by patients and clinicians. How-
ever, at T2 compared to the control group, patients in the intervention arm reported a
significantly better application of SDM (d = 0.32). At T1, the differences in the SDM-Q-9
scores, reported by patients and clinicians, between the two arms were not significant. Look-
ing at treatment outcome, measured by the SQ-48, we found a significant positive interven-
tion effect at T2. Patients of the intervention group, reported more symptom reduction at T2,
with a medium effect size (d = -0.43). The other secondary outcome parameters, patient par-
ticipation, working alliance and treatment adherence did not differ between the two arms.
Irrespective of the condition, a better application of SDM according to patients was associ-
ated with less DC (d = -1.31), which in turn had a positive influence on treatment outcome
(d = 0.45).
Strengths and limitations
First strength of the study design is the matched pair randomisation of similar intake teams,
which reduced the risk of confounding shown by the balance in patients’ characteristics in the
two arms. Second, because independent research assistants, who were blinded for the study
arm during inclusion, asked all patients who met the inclusion criteria to participate in the
trial, selection bias was prevented as much as possible. Third, the mainly independent data col-
lection, coordinated by independent research assistants, with separate research instruments
apart from the intake intervention, which results were not visible at patient level during the
intake and treatment, prevented socially desirable answers of patients and undesired influence
of the research team or clinicians on the results. Only the regular ROM, measuring symptom
severity, was used by both arms during intake and treatment. Furthermore, the external valid-
ity of this study to the patient population with primary diagnoses mood, anxiety or personality
disorders treated in Dutch specialist mental health care proved to be good. Finally, we used
multilevel analyses to correct for the clustering of the results at the levels of teams and intake-
clinicians. At the team level, which was our level of randomisation, we did not find variability
between clusters, probably because of the matched pair cluster randomisation between two
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equal teams, which belong to the same mental health organisation. At the level of intake clini-
cians we found a significant cluster effect with an ICC of 0.10. This finding can be explained
by the nature of the intervention and the association between the level of SDM with the collab-
oration style, attitude and skills of the clinicians. Previous research among patients in mental
health care showed the association of the patient-clinician working alliance on patient partici-
pation in decision making [33–35]. Patients even indicate that the quality of the relationship
with their clinician is the most important component that influences SDM [33, 34]. In fact,
this is confirmed in our study by the clustering of results at clinicians’ level. In addition, train-
ing of the clinicians was an important part of the intervention. A high clustering of the effects
at clinicians’ level, can probably also be explained by the fact that the training of clinicians has
not the same impact on the participants. The effect of the training might be dependent on the
initial level of SDM application and the learning attitude of the clinicians. Subsequently, we
recommend to get more insight in the association of clinicians’ characteristics on the applica-
tion of SDM. If we have more insight in these associations, we were able to tailor future inter-
ventions to specific characteristics and needs of clinicians.
This study also has a number of limitations that could have influenced the results.
Although, we adopted a cluster randomised controlled design to reduce the risk of cross over
effects between the two arms, contamination between the clinicians of the teams cannot be
ruled out completely and may have weakened the effects found. Cross over effects between
patients were unlikely, because they followed the intake and treatment individually and hence
did not meet and know each other. Furthermore, because patients and clinicians were not
blinded for the design, it was possible that patients and clinicians from the control teams,
made additional efforts in SDM. Research assistants were partially blinded for the study arm,
however they could have hardly influenced the results, because the outcome parameters were
measured by self-report questionnaires, completed by patients and clinicians. As described
more comprehensively in the section ‘interpretation and clinical implications’, the uptake of
the intervention was not optimal, especially not on the patients’ side of the dyad. Finally, to dis-
cuss the results of the intake module, in the intervention group the initial intake consult took
30 minutes longer compared to the control group. Although, previous research did not show
that applying SDM takes more time [36], the extra time of the first intake consultation in the
intervention group could be a confounder, because it might have given more possibilities for
the patient and clinician to go through the steps in the SDM process carefully. Maybe, there-
fore patients in the intervention group may have felt more support to participate actively in
decision making [7].
Generalizability
This study was performed in real world clinical practice. Departments of two catchment areas
(urban, semi-urban and rural as well) participated in this trial. The participating departments
were specialised in the treatment of patients with mood, anxiety and personality disorders.
Except of patients who did not speak and read the Dutch language or were unable to answer
questionnaires, because of an ongoing crisis or cognitive functioning, all patients were asked
to participate. Moreover, the population of 200 participating patients, which was in balance
between the two arms, was larger than the estimated sample size of 176. Taken together, it is
reasonable to assume that the study results are generalizable to the patient population with
mood, anxiety and personality disorders treated in Dutch specialist mental health care.
Regarding the exclusion criteria and the focus of the intervention on three diagnosis groups,
the current study might not be generalizable to a broader patient population with other diag-
noses and patients who were incapable to answer questionnaires.
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Interpretation and clinical implications
To our knowledge, no previous RCT has investigated a multi-facetted intervention aimed to
improve SDM in specialist mental health care, targeting both patients’ and clinicians’ behav-
iour during the intake process. Although previous research [7,14,15] pointed out that to
enhance SDM it is important to support both sides of the dyad, until now it was unclear
whether patients benefit from the implementation of such a novel combined SDM, blended
eHealth, ROM and peer support initiative facilitating both patients and clinicians during the
intake process in routine clinical practice. In contrast with our hypotheses we found no signifi-
cant differences between SDM-DI and IAU regarding Decisional Conflict (DC) experienced
by patients, which was our primary outcome. We also did not find effects on the secondary
outcomes patient participation, working alliance and treatment adherence. However, in con-
cordance with our expectations, in the intervention arm patients reported that the application
of SDM by clinicians was better, and they also reported less symptom severity. Moreover, it
was very encouraging to see that a higher level of applying SDM led to less DC, which was pos-
itively associated with reduction of symptoms.
The lack of effects in the intervention arm on the primary outcome and some of the second-
ary outcome parameters, might be explained by the fact that the uptake of SDM-DI in the
intervention arm was not sufficient. Possibly, regarding the less than optimal intervention
integrity and no significant effect on the secondary outcome patient participation, more sup-
port was needed on the patients’ side of the dyad to foster a higher level of patient participation
in decision making, which in turn might reduce DC. Whereas, due to the training in SDM
skills, clinicians participating in the intervention group actually applied the SDM-steps during
intake consultations. Hence, compared to the control group, patients in the intervention
group reported a higher level of SDM applicated by clinicians, while this is probably not
enough to influence patient reported DC. Nevertheless, patients in the intervention group
reported less symptom severity, while we hypothesized this improvement in treatment out-
come as a result of reduced DC. In line with this expectation, explorative analyses showed the
association between less DC and less symptom severity. A possible explanation of the positive
findings on symptom severity in the intervention arm without a change in DC might be that
the personalised, recovery oriented attention which was applied in the intervention group,
could also influence treatment outcome directly. Looking at the level of DC among patients
(Table 2), we can conclude, that there is still room for improvement, because patients in spe-
cialist mental health care experience relatively high levels of DC [8], which also applies to
patients participating in this study.
To improve the uptake of the intervention, more time and efforts are needed to change the
attitudes of clinicians and patients more fundamentally towards SDM [7,11,37,38], in this
study especially on the patients’ side of the dyad. Lessons from the implementation of SDM
pointed out that the implementation of SDM is a challenging process, which need a bundle of
interventions targeting to foster cultural change among patients and clinicians towards SDM
as usual practice [11,38,39]. Furthermore, previous research about the implementation of
eHealth demonstrated the importance of organising sufficient support to clinicians (i.e. regular
supervision sessions) targeting to integrate the application of eHealth tools in their daily work-
ing practice [40]. To prepare patients for their active role and give them greater confidence in
decisional involvement, patients might need more flexible, personalized support, training and
better introduced (digital) tools [7,15,37,41,42]. Previous research and feedback from patients
and clinicians, who participated in the intervention group of this study, showed that the imple-
mentation of SDM in the intake could have been improved if the eHealth modules with ROM
had been better introduced to patients, for example before the intake consultation by peer
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workers, making it more clear to patients how these tools could help them during the intake
process [43,44]. In addition, feedback from the participants showed that if the design of the
eHealth modules was more simplified, it would be more attractive to follow the eHealth mod-
ules completely.
At the same time, we have limited insight in what happened with patients while following
the eHealth modules and we also know less about patients’ preferences about using eHealth
and peer support. We only have insight in the percentage technically completed eHealth mod-
ules and the fact that peer workers were hardly contacted in the intake process. In future
research, it would be interesting to explore these user patterns and preferences, and also inves-
tigate the associations between the use of eHealth and peer support with patients characteris-
tics, the level of participation in decision making and treatment outcome. This could give us
more insight in which way of working with eHealth and peer support works for whom.
Although, this is a negative trial and we found limited effects of SDM-DI on the secondary
outcomes, it was encouraging to find that, irrespective of the condition, a better application of
SDM, leads to less DC experienced by patients, which in turn was associated with more symp-
tom reduction. This finding was in line with previous, national research to shared decision
making using ROM in Dutch specialist mental health care, where the positive influence of a
higher level of SDM on reduced DC, and the effects on treatment outcomes were also shown
[22].
Conclusions
This innovative study stimulated SDM at both sides of the patient-clinician dyad using a com-
bination of digital and face-to-face methods, i.e. digital exploration of patients’ treatment
needs and preferences facilitated by ROM, peer support and training of clinicians. The trial
showed no effects of SDM-DI on Decisional Conflict, patient participation, working alliance
and treatment adherence. However, compared to the control group, in the intervention group
positive effects were reported regarding the application of SDM and symptom severity, which
is the most important outcome of treatment. Furthermore, irrespective of the condition, this
study demonstrated that when SDMwas applied well, this approach led to less Decisional Con-
flict, which in turn had a positive influence on treatment outcome. Taken together, the study
results pointed out that the application of a SDM intervention in the intake process targeting
both patients’ and clinicians’ behaviour is a promising approach, which requires thorough
implementation and continuation during treatment. Additionally, further exploration is
needed to find out which interventions would help patients and clinicians best to foster patient
participation in decision making about treatment.
Registration
The trial is registered in the Dutch trial register with number: NTR5677 and registration date:
17 January 2016 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5677).
Protocol
Full details of the trial protocol [16] can be found at: https://doi.org/10.1186/s12888-017-
1247-9.
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